- December 11, 2019
- Category: Healthcare and LifeSciences, Medical Diagnostics
Global Sepsis Diagnostics Market Size Study, by Technology (Microbiology, Molecular Diagnostics, Immunoassay, Flow Cytometry, Microfluidics, Biomarkers) by Product (Instruments, Blood-Culture Media, Assays & Reagents, Software) by Method (Conventional Diagnostics, Automated Diagnostics) by Test-Type (Laboratory, Point-of-Care) by End-Use (Hospital, Pathology & Reference Laboratories) and Regional Forecasts 2019-2026
| Product Code: | HALMD_68283649 |
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million) 1.2.1. Sepsis Diagnostic Market, by Technology, 2017-2026 (USD Million) 1.2.2. Sepsis Diagnostic Market, by Product, 2017-2026 (USD Million) 1.2.3. Sepsis Diagnostic Market, by Method, 2017-2026 (USD Million) 1.2.4. Sepsis Diagnostic Market, by Test-Type, 2017-2026 (USD Million) 1.2.5. Sepsis Diagnostic Market, by End-Use, 2017-2026 (USD Million) 1.2.6. Sepsis Diagnostic Market, by Region, 2017-2026 (USD Million) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Sepsis Diagnostic Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Sepsis Diagnostic Market Dynamics 3.1. Sepsis Diagnostic Market Impact Analysis (2018-2026) 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Sepsis Diagnostic Market Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Sepsis Diagnostic Market by Technology 5.1. Market Snapshot 5.2. Global Sepsis Diagnostic Market by Technology, Performance - Potential Analysis 5.3. Global Sepsis Diagnostic Market Estimates & Forecasts by Technology 2016-2026 (USD Million) 5.4. Sepsis Diagnostic Market, Sub Segment Analysis 5.4.1. Microbiology 5.4.2. Molecular Diagnostics 5.4.3. Immunoassay 5.4.4. Flow Cytometry 5.4.5. Microfluidics 5.4.6. Biomarkers Chapter 6. Global Sepsis Diagnostic Market, by Product 6.1. Market Snapshot 6.2. Global Sepsis Diagnostic Market by Product, Performance - Potential Analysis 6.3. Global Sepsis Diagnostic Market Estimates & Forecasts by Product, 2016-2026 (USD Million) 6.4. Sepsis Diagnostic Market, Sub Segment Analysis 6.4.1. Instruments 6.4.2. Blood-Culture Media 6.4.3. Assays & Reagents 6.4.4. Software Chapter 7. Global Sepsis Diagnostic Market by Method 7.1. Market Snapshot 7.2. Global Sepsis Diagnostic Market by Method, Performance - Potential Analysis 7.3. Global Sepsis Diagnostic Market Estimates & Forecasts by Method, 2016-2026 (USD Million) 7.4. Sepsis Diagnostic Market, Sub Segment Analysis 7.4.1. Conventional Diagnostics 7.4.2. Automated Diagnostics Chapter 8. Global Sepsis Diagnostic Market by Test-Type 8.1. Market Snapshot 8.2. Global Sepsis Diagnostic Market by Test-Type - Potential Analysis 8.3. Global Sepsis Diagnostic Market Estimates & Forecasts by Test-Type, 2016-2026 (USD Million) 8.4. Sepsis Diagnostic Market, Sub Segment Analysis 8.4.1. Laboratory Tests 8.4.2. Point-Of-Care Tests Chapter 9. Global Sepsis Diagnostic Market by End-Use 9.1. Market Snapshot 9.2. Global Sepsis Diagnostic Market by End-Use, - Potential Analysis 9.3. Global Sepsis Diagnostic Market Estimates & Forecasts by End-Use, 2016-2026 (USD Million) 9.4. Sepsis Diagnostic Market, Sub Segment Analysis 9.4.1. Hospitals 9.4.2. Pathology & Reference Laboratories Chapter 10. Global Sepsis Diagnostic Market, Regional Analysis 10.1. Sepsis Diagnostic Market, Regional Market Snapshot 10.2. North America Sepsis Diagnostic Market 10.2.1. U.S. Sepsis Diagnostic Market 10.2.1.1. Technology breakdown estimates & forecasts, 2016-2026 10.2.1.2. Product breakdown estimates & forecasts, 2016-2026 10.2.1.3. Method breakdown estimates & forecasts, 2016-2026 10.2.1.4. Test-Type breakdown estimates & forecasts, 2016-2026 10.2.1.5. End-Use breakdown estimates & forecasts, 2016-2026 10.2.2. Canada Sepsis Diagnostic Market 10.3. Europe Sepsis Diagnostic Market Snapshot 10.3.1. U.K. Sepsis Diagnostic Market 10.3.2. Germany Sepsis Diagnostic Market 10.3.3. Rest of Europe Sepsis Diagnostic Market 10.4. Asia-Pacific Sepsis Diagnostic Market Snapshot 10.4.1. China Sepsis Diagnostic Market 10.4.2. India Sepsis Diagnostic Market 10.4.3. Japan Sepsis Diagnostic Market 10.4.4. Rest of Asia Pacific Sepsis Diagnostic Market 10.5. Latin America Sepsis Diagnostic Market Snapshot 10.5.1. Brazil Sepsis Diagnostic Market 10.5.2. Mexico Sepsis Diagnostic Market 10.6. Rest of The World Sepsis Diagnostic Market Chapter 11. Competitive Intelligence 11.1. Top Market Strategies 11.2. Company Profiles 11.2.1. Biomerieux 11.2.1.1. Key Information 11.2.1.2. Overview 11.2.1.3. Financial (Subject To Data Availability) 11.2.1.4. Product Summary 11.2.1.5. Recent Developments 11.2.2. T2 Biosystems 11.2.3. Luminex 11.2.4. Becton, Dickinson, & Company (BD) 11.2.5. Roche Diagnostics 11.2.6. Danaher 11.2.7. Thermo Fisher Scientific 11.2.8. Bruker 11.2.9. Abbott 11.2.10. Axis-Shield Diagnostics 11.2.11. Cytosorbents 11.2.12. Mitsubishi Chemical Europe 11.2.13. EKF Diagnostics 11.2.14. Immunexpress Chapter 12. Research Process 12.1. Research Process 12.1.1. Data Mining 12.1.2. Analysis 12.1.3. Market Estimation 12.1.4. Validation 12.1.5. Publishing 12.2. Research Attributes 12.3. Research Assumption
Global Sepsis Diagnostics Market valued approximately USD 403.95 million in 2018 is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2019-2026. Sepsis means reaction of the body to the bacterial, viral, fungal, or parasitic infection, that may further lead to inflammatory reaction and organ failure or organ dysfunction. It affects several people in different manner as per their severity of infection, race, ethnicity, age etc. It is more common in the elderly and infants’. Major drivers such as increasing prevalence of sepsis across the world, growing geriatric population, increasing government initiatives for sepsis awareness, and increasing incidence of hospital-acquired infections are likely to give growth to the sepsis diagnosis market. For instance, according to United Nations’ report: World Population Prospect-The 2017 Revision, worldwide population of people aged over 60 years is projected to increase from 962 million in 2017 (13% of world population) to 1.3 billion by 2030 and will reach to 2.1 billion by 2050. The report further stated that the population (of people aged over 60 years) is expected to increase at a rate of 3% annually, by 2050, nearly in all regions except Africa which would have 25% or more population of against entire population with age 60 or more. Thus, growing number of aging population possibly increases the prevalence of sepsis, thus enhancing the need for sepsis diagnostic around the world. However, lack of established reimbursement policies for sepsis and high cost of automated diagnostic devices are few factors limiting the growth of the market over the forecast period.
The regional analysis of Global Sepsis Diagnostic Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-Pacific is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as U.S. and Canada, North America region is anticipated to be the dominating region over the forecast period owing to the presence of a well-established healthcare infrastructure in the region.
The leading player of market included in this report are:
Biomerieux
T2 Biosystems
Luminex
Becton, Dickinson, & Company (BD)
Roche Diagnostics
Danaher
Thermo Fisher Scientific
Bruker
Abbott
Axis-Shield Diagnostics
Cytosorbents
Mitsubishi Chemical Europe
EKF Diagnostics
Immunexpress
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Microbiology
Molecular Diagnostics
Immunoassay
Flow Cytometry
Microfluidics
Biomarkers
By Product:
Instruments
Blood-Culture Media
Assays & Reagents
Software
By Method:
Conventional Diagnostics
Automated Diagnostics
By Test Type:
Laboratory
Point-Of-Care Tests
By End-Use:
Hospitals
Pathology & Reference Laboratories
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Sepsis Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors